|
Volumn 36, Issue 3, 2010, Pages 428-430
|
Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before mohs micrographic surgery: A randomized, double-blind, vehicle-controlled study
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
IMIQUIMOD;
AMINOQUINOLINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ADJUVANT THERAPY;
BASAL CELL CARCINOMA;
CANCER RADIOTHERAPY;
CANCER RESISTANCE;
CANCER THERAPY;
CHEMOSURGERY;
CLINICAL TRIAL;
CRYOTHERAPY;
DERMATOFIBROSARCOMA PROTUBERANS;
HISTIOCYTOMA;
HISTOLOGY;
HUMAN;
INFLAMMATION;
LETTER;
MALIGNANT LENTIGO;
MELANOMA;
PAGET SKIN DISEASE;
PHOTODYNAMIC THERAPY;
PRIORITY JOURNAL;
SEBACEOUS GLAND;
SQUAMOUS CELL CARCINOMA;
TREATMENT DURATION;
TUMOR LOCALIZATION;
NOSE TUMOR;
NOTE;
PATHOLOGY;
SKIN TUMOR;
AMINOQUINOLINES;
ANTINEOPLASTIC AGENTS;
CARCINOMA, BASAL CELL;
HUMANS;
MOHS SURGERY;
NEOADJUVANT THERAPY;
NOSE NEOPLASMS;
SKIN NEOPLASMS;
|
EID: 77749239937
PISSN: 10760512
EISSN: 15244725
Source Type: Journal
DOI: 10.1111/j.1524-4725.2009.01464.x Document Type: Letter |
Times cited : (9)
|
References (4)
|